Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Parkinson’s model miceKentaro Togashi, Toshio Ohshima, Yoshio Goshima et al.|Genes to Cells|2018Cited by 18
Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activationKentaro Togashi, Toshio Ohshima, Masaya Hasegawa et al.|Journal of the Neurological Sciences|2020Cited by 10
Phosphorylation of CRMP2 is required for migration and positioning of Purkinje cells: Redundant roles of CRMP1 and CRMP4Yuki Yamazaki, Toshio Ohshima, Yoshio Goshima et al.|Brain Research|2020Cited by 8